Study identifier:NIS-CFR-CRE-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Statins and risk of myocardial infarction in real life in France
myocardial infarction
-
Yes
-
All
13171
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
The main objective of this case-referent study is to assess the impact of statins usage on the risk of having a first myocardial infarction (MI) in a real life situation in France
Location
Location
Ambilly, France
Location
Angers, France
Location
Arles, France
Location
Bagnols sur Ceze, France
Location
Bayonne, France
Location
Beziers, France
Location
Boulogne sur mer, France
Location
Bourgoin Jallieu, France
Arms | Assigned Interventions |
---|---|
1 Cases : Patients with a first myocardial infarction | - |
2 Referents : Patients recruited by a GP during a routine consultation | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.